Healthcare Sector Stocks
The Healthcare sector has a total of 1056 stocks, with a combined market cap of $8.98 trillion, total revenue of $4.59 trillion and a weighted average PE ratio of 45.06.
Market Cap
8.98T
Revenue
4.59T
Profits
199.3B
PE Ratio
45.06
Profit Margin
4.34%
Dividend Yield
0.39%
1056 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.06T | -1.21% | 674,846 | 72.25B |
| 2 | JNJ | Johnson & Johnson | 608.57B | -0.46% | 1,224,525 | 96.36B |
| 3 | ABBV | AbbVie Inc. | 441.56B | -0.68% | 1,151,429 | 62.82B |
| 4 | UNH | UnitedHealth Group Incorporated | 382.49B | 1.34% | 1,383,541 | 449.71B |
| 5 | MRK | Merck & Co., Inc. | 313.10B | -1.35% | 1,796,452 | 65.77B |
| 6 | AZN | AstraZeneca PLC | 290.16B | -2.66% | 963,017 | 60.44B |
| 7 | NVS | Novartis AG | 286.77B | -1.54% | 555,638 | 56.58B |
| 8 | NVO | Novo Nordisk A/S | 212.92B | 2.43% | 4,188,700 | 50.57B |
| 9 | AMGN | Amgen Inc. | 194.81B | -0.32% | 472,293 | 37.22B |
| 10 | TMO | Thermo Fisher Scientific Inc. | 192.52B | 3.33% | 426,274 | 45.20B |
| 11 | ABT | Abbott Laboratories | 162.89B | 3.06% | 3,862,793 | 45.13B |
| 12 | GILD | Gilead Sciences, Inc. | 157.03B | 0.11% | 1,179,954 | 29.74B |
| 13 | ISRG | Intuitive Surgical, Inc. | 144.57B | 2.65% | 500,926 | 10.58B |
| 14 | DHR | Danaher Corporation | 138.60B | 2.81% | 795,461 | 24.78B |
| 15 | PFE | Pfizer Inc. | 136.50B | -0.54% | 8,518,983 | 63.32B |
| 16 | CVS | CVS Health Corporation | 133.18B | 0.90% | 1,138,394 | 405.62B |
| 17 | VRTX | Vertex Pharmaceuticals Incorporated | 126.58B | 0.40% | 231,522 | 12.22B |
| 18 | SYK | Stryker Corporation | 122.01B | 1.09% | 500,555 | 25.27B |
| 19 | BMY | Bristol-Myers Squibb Company | 115.60B | -1.75% | 2,311,178 | 48.48B |
| 20 | GSK | GSK plc | 104.73B | -1.83% | 906,835 | 43.29B |
| 21 | SNY | Sanofi | 102.95B | -2.63% | 1,653,425 | 54.60B |
| 22 | MDT | Medtronic plc | 102.11B | 1.97% | 1,811,907 | 36.36B |
| 23 | MCK | McKesson Corporation | 89.93B | 1.66% | 221,283 | 403.43B |
| 24 | HCA | HCA Healthcare, Inc. | 87.35B | 0.99% | 231,769 | 76.39B |
| 25 | ELV | Elevance Health, Inc. | 86.27B | 2.73% | 232,894 | 200.42B |
| 26 | CI | The Cigna Group | 73.12B | 0.26% | 377,172 | 277.89B |
| 27 | REGN | Regeneron Pharmaceuticals, Inc. | 64.34B | 1.42% | 245,577 | 14.92B |
| 28 | BSX | Boston Scientific Corporation | 64.03B | 0.94% | 6,388,212 | 20.61B |
| 29 | ARGX | argenx SE | 57.65B | -2.11% | 144,267 | 4.74B |
| 30 | COR | Cencora, Inc. | 55.98B | 1.68% | 202,228 | 328.68B |
| 31 | CAH | Cardinal Health, Inc. | 55.69B | 0.09% | 243,826 | 250.74B |
| 32 | MDLN | Medline Inc. | 53.64B | 3.52% | 1,753,997 | 29.14B |
| 33 | EW | Edwards Lifesciences Corporation | 52.84B | 1.44% | 603,895 | 6.30B |
| 34 | TAK | Takeda Pharmaceutical Company Limited | 50.06B | -0.31% | 550,926 | 28.34B |
| 35 | HUM | Humana Inc. | 49.13B | 3.02% | 279,564 | 137.20B |
| 36 | IDXX | IDEXX Laboratories, Inc. | 42.40B | 2.10% | 115,990 | 4.45B |
| 37 | BDX | Becton, Dickinson and Company | 42.04B | 0.82% | 465,810 | 22.23B |
| 38 | ALNY | Alnylam Pharmaceuticals, Inc. | 41.09B | 2.24% | 242,047 | 4.29B |
| 39 | HLN | Haleon plc | 40.67B | 1.29% | 3,685,995 | 14.85B |
| 40 | RVMD | Revolution Medicines, Inc. | 39.84B | 0.06% | 607,856 | - |
| 41 | TEVA | Teva Pharmaceutical Industries Limited | 39.44B | -0.03% | 1,243,845 | 17.35B |
| 42 | NTRA | Natera, Inc. | 38.99B | 0.29% | 457,580 | 2.50B |
| 43 | A | Agilent Technologies, Inc. | 38.19B | 1.79% | 326,941 | 7.23B |
| 44 | WAT | Waters Corporation | 37.45B | 1.71% | 211,216 | 3.77B |
| 45 | IQV | IQVIA Holdings Inc. | 34.35B | 6.51% | 635,880 | 16.63B |
| 46 | CNC | Centene Corporation | 33.25B | 4.91% | 1,532,967 | 178.33B |
| 47 | ALC | Alcon Inc. | 32.96B | -0.42% | 1,062,529 | 10.63B |
| 48 | ONC | BeOne Medicines AG | 32.23B | 1.74% | 129,256 | 5.70B |
| 49 | RPRX | Royalty Pharma plc | 32.05B | -0.73% | 349,249 | 2.44B |
| 50 | BIIB | Biogen Inc. | 31.51B | -1.20% | 172,803 | 9.94B |
| 51 | ZTS | Zoetis Inc. | 31.13B | 3.34% | 2,008,132 | 9.53B |
| 52 | VEEV | Veeva Systems Inc. | 30.57B | 6.03% | 547,736 | 3.32B |
| 53 | GEHC | GE HealthCare Technologies Inc. | 29.82B | 2.42% | 587,846 | 20.98B |
| 54 | RMD | ResMed Inc. | 29.32B | 4.17% | 298,428 | 5.54B |
| 55 | MRNA | Moderna, Inc. | 28.84B | 3.78% | 2,263,603 | 2.23B |
| 56 | ILMN | Illumina, Inc. | 27.49B | 3.35% | 397,152 | 4.39B |
| 57 | DXCM | DexCom, Inc. | 26.67B | 2.63% | 1,320,643 | 4.82B |
| 58 | MTD | Mettler-Toledo International Inc. | 26.40B | 2.26% | 57,404 | 4.09B |
| 59 | PHG | Koninklijke Philips N.V. | 25.84B | 0.51% | 204,762 | 20.34B |
| 60 | WST | West Pharmaceutical Services, Inc. | 25.65B | 1.11% | 176,639 | 3.22B |
| 61 | ROIV | Roivant Sciences Ltd. | 25.20B | -1.02% | 713,767 | 8.26M |
| 62 | DGX | Quest Diagnostics Incorporated | 23.81B | 1.47% | 139,170 | 11.28B |
| 63 | BNTX | BioNTech SE | 23.46B | -0.32% | 124,065 | 3.23B |
| 64 | LH | Labcorp Holdings Inc. | 23.43B | 2.07% | 112,388 | 14.14B |
| 65 | INSM | Insmed Incorporated | 23.11B | - | 409,058 | 819.56M |
| 66 | UTHR | United Therapeutics Corporation | 22.95B | -0.22% | 44,390 | 3.17B |
| 67 | INCY | Incyte Corporation | 22.76B | 0.49% | 310,868 | 5.36B |
| 68 | GH | Guardant Health, Inc. | 21.31B | 7.13% | 2,163,898 | 1.08B |
| 69 | STE | STERIS plc | 20.88B | 1.76% | 188,476 | 5.94B |
| 70 | VTRS | Viatris Inc. | 18.84B | 1.86% | 1,909,094 | 14.56B |
| 71 | NBIX | Neurocrine Biosciences, Inc. | 16.89B | -0.35% | 204,039 | 3.10B |
| 72 | GMAB | Genmab A/S | 16.84B | -0.07% | 631,258 | 3.90B |
| 73 | ZBH | Zimmer Biomet Holdings, Inc. | 16.59B | -0.41% | 753,727 | 8.41B |
| 74 | ASND | Ascendis Pharma A/S | 16.40B | -1.01% | 99,253 | 998.25M |
| 75 | THC | Tenet Healthcare Corporation | 16.35B | 1.46% | 334,869 | 21.46B |
| 76 | MEDP | Medpace Holdings, Inc. | 15.70B | 3.83% | 61,170 | 2.68B |
| 77 | JAZZ | Jazz Pharmaceuticals plc | 14.99B | -0.84% | 145,524 | 4.44B |
| 78 | BBIO | BridgeBio Pharma, Inc. | 14.63B | 0.31% | 413,898 | 579.96M |
| 79 | DVA | DaVita Inc. | 14.62B | 2.36% | 141,023 | 13.84B |
| 80 | COO | The Cooper Companies, Inc. | 14.31B | 2.34% | 1,509,741 | 4.23B |
| 81 | BTSG | BrightSpring Health Services, Inc. | 14.30B | -1.55% | 400,154 | 13.65B |
| 82 | ICLR | ICON Public Limited Company | 13.81B | 3.75% | 232,582 | 8.27B |
| 83 | SOLV | Solventum Corporation | 13.72B | 2.72% | 227,823 | 8.26B |
| 84 | EXEL | Exelixis, Inc. | 13.51B | -1.19% | 337,639 | 2.38B |
| 85 | IONS | Ionis Pharmaceuticals, Inc. | 13.01B | -0.74% | 369,842 | 1.06B |
| 86 | ALGN | Align Technology, Inc. | 12.85B | 6.42% | 351,232 | 4.10B |
| 87 | RVTY | Revvity, Inc. | 12.70B | 2.34% | 473,428 | 2.90B |
| 88 | AXSM | Axsome Therapeutics, Inc. | 12.56B | -0.31% | 143,987 | 708.24M |
| 89 | ELAN | Elanco Animal Health Incorporated | 12.49B | 1.61% | 553,484 | 4.89B |
| 90 | PEN | Penumbra, Inc. | 12.45B | 0.29% | 133,646 | 1.45B |
| 91 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.34B | -0.30% | 40,816 | 1.13B |
| 92 | SNN | Smith & Nephew plc | 12.28B | 1.39% | 475,112 | 6.16B |
| 93 | FMS | Fresenius Medical Care AG | 12.15B | 1.37% | 212,992 | 22.32B |
| 94 | MOH | Molina Healthcare, Inc. | 12.00B | 0.76% | 193,954 | 43.10B |
| 95 | RDY | Dr. Reddy's Laboratories Limited | 11.80B | -2.59% | 546,226 | 3.58B |
| 96 | CYTK | Cytokinetics, Incorporated | 11.54B | -0.21% | 458,051 | 105.82M |
| 97 | ARWR | Arrowhead Pharmaceuticals, Inc. | 11.53B | 0.42% | 479,554 | 622.01M |
| 98 | SMMT | Summit Therapeutics Inc. | 11.33B | 0.21% | 1,066,039 | - |
| 99 | CRL | Charles River Laboratories International, Inc. | 11.31B | 3.58% | 181,483 | 4.03B |
| 100 | BMRN | BioMarin Pharmaceutical Inc. | 11.31B | 2.24% | 406,219 | 3.24B |
| 101 | BAX | Baxter International Inc. | 11.21B | 1.78% | 1,384,622 | 11.32B |
| 102 | TEM | Tempus AI, Inc. | 11.10B | 6.73% | 3,600,332 | 1.36B |
| 103 | PODD | Insulet Corporation | 11.08B | 5.06% | 292,082 | 2.90B |
| 104 | TECH | Bio-Techne Corporation | 11.02B | 0.13% | 5,341,266 | 1.21B |
| 105 | KRYS | Krystal Biotech, Inc. | 10.93B | -0.21% | 64,161 | 417.30M |
| 106 | GMED | Globus Medical, Inc. | 10.61B | -1.06% | 518,221 | 3.10B |
| 107 | ABVX | ABIVAX Société Anonyme | 10.52B | 1.62% | 2,220,181 | 5.67M |
| 108 | EHC | Encompass Health Corporation | 10.17B | 1.43% | 107,544 | 6.07B |
| 109 | APGE | Apogee Therapeutics, Inc. | 9.95B | 0.01% | 1,572,483 | - |
| 110 | NUVL | Nuvalent, Inc. | 9.76B | 0.08% | 302,289 | - |
| 111 | HSIC | Henry Schein, Inc. | 9.71B | 2.05% | 174,630 | 13.38B |
| 112 | CORT | Corcept Therapeutics Incorporated | 9.67B | 3.58% | 260,760 | 769.10M |
| 113 | ENSG | The Ensign Group, Inc. | 9.64B | 3.77% | 136,296 | 5.27B |
| 114 | BRKR | Bruker Corporation | 9.50B | 3.76% | 795,022 | 3.46B |
| 115 | KYMR | Kymera Therapeutics, Inc. | 9.50B | 0.75% | 143,559 | 51.48M |
| 116 | OSCR | Oscar Health, Inc. | 9.41B | 9.54% | 1,868,537 | 13.30B |
| 117 | IBRX | ImmunityBio, Inc. | 9.37B | 2.23% | 4,670,184 | 140.98M |
| 118 | PRAX | Praxis Precision Medicines, Inc. | 9.18B | -1.64% | 118,428 | 7.46M |
| 119 | UHS | Universal Health Services, Inc. | 9.11B | 1.22% | 206,201 | 17.76B |
| 120 | HALO | Halozyme Therapeutics, Inc. | 9.10B | -1.94% | 273,472 | 1.51B |
| 121 | HIMS | Hims & Hers Health, Inc. | 8.80B | 9.66% | 12,782,442 | 2.37B |
| 122 | ALKS | Alkermes plc | 8.52B | -2.41% | 354,624 | 1.56B |
| 123 | GKOS | Glaukos Corporation | 8.28B | 0.88% | 79,978 | 551.35M |
| 124 | PCVX | Vaxcyte, Inc. | 8.18B | -2.56% | 250,134 | - |
| 125 | QGEN | Qiagen N.V. | 8.13B | 0.51% | 392,246 | 2.10B |
| 126 | ATR | AptarGroup, Inc. | 8.08B | 1.16% | 68,082 | 3.87B |
| 127 | BIO | Bio-Rad Laboratories, Inc. | 7.99B | 1.66% | 48,873 | 2.59B |
| 128 | PTGX | Protagonist Therapeutics, Inc. | 7.97B | 1.10% | 99,501 | 74.06M |
| 129 | HQY | HealthEquity, Inc. | 7.93B | 4.97% | 229,589 | 1.34B |
| 130 | RGEN | Repligen Corporation | 7.91B | 2.83% | 351,225 | 763.34M |
| 131 | IMVT | Immunovant, Inc. | 7.83B | -1.01% | 137,993 | - |
| 132 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.80B | 2.52% | 197,297 | 217.17M |
| 133 | TGTX | TG Therapeutics, Inc. | 7.75B | -0.53% | 354,844 | 700.35M |
| 134 | SYRE | Spyre Therapeutics, Inc. | 7.60B | -1.45% | 342,537 | - |
| 135 | LNTH | Lantheus Holdings, Inc. | 7.26B | 0.46% | 130,224 | 1.55B |
| 136 | MIRM | Mirum Pharmaceuticals, Inc. | 7.21B | 0.97% | 162,547 | 569.61M |
| 137 | LQDA | Liquidia Corporation | 7.04B | -0.69% | 277,006 | 288.07M |
| 138 | PACS | PACS Group, Inc. | 6.94B | 2.81% | 269,270 | 5.43B |
| 139 | AVTR | Avantor, Inc. | 6.88B | 1.77% | 2,411,022 | 6.55B |
| 140 | PTCT | PTC Therapeutics, Inc. | 6.76B | -0.05% | 211,728 | 827.11M |
| 141 | HNGE | Hinge Health, Inc. | 6.65B | 3.60% | 333,073 | 646.34M |
| 142 | COGT | Cogent Biosciences, Inc. | 6.65B | 0.47% | 955,850 | - |
| 143 | SRRK | Scholar Rock Holding Corporation | 6.49B | -1.56% | 232,915 | - |
| 144 | TWST | Twist Bioscience Corporation | 6.42B | 0.26% | 416,037 | 409.48M |
| 145 | CHE | Chemed Corporation | 6.32B | 2.59% | 73,205 | 2.54B |
| 146 | LGND | Ligand Pharmaceuticals Incorporated | 6.25B | -0.20% | 130,120 | 274.48M |
| 147 | CGON | CG Oncology, Inc. | 6.20B | -1.01% | 150,108 | 5.07M |
| 148 | GRFS | Grifols, S.A. | 6.18B | -0.42% | 552,755 | 8.58B |
| 149 | BLCO | Bausch + Lomb Corporation | 6.04B | 2.29% | 125,883 | 5.21B |
| 150 | BLTE | Belite Bio, Inc | 6.01B | -0.77% | 109,503 | - |
| 151 | DFTX | Definium Therapeutics, Inc. | 5.96B | -4.56% | 801,079 | - |
| 152 | XENE | Xenon Pharmaceuticals Inc. | 5.83B | -0.15% | 231,482 | 7.50M |
| 153 | TFX | Teleflex Incorporated | 5.78B | 3.01% | 56,273 | 2.13B |
| 154 | LEGN | Legend Biotech Corporation | 5.72B | 2.32% | 515,315 | 1.14B |
| 155 | BLLN | BillionToOne, Inc. | 5.70B | 3.29% | 164,231 | 354.54M |
| 156 | ORKA | Oruka Therapeutics, Inc. | 5.69B | -0.79% | 420,470 | - |
| 157 | ERAS | Erasca, Inc. | 5.54B | -2.73% | 1,221,092 | - |
| 158 | MANE | Veradermics, Incorporated | 5.47B | 6.56% | 132,798 | - |
| 159 | CRSP | CRISPR Therapeutics AG | 5.41B | 2.81% | 365,589 | 4.10M |
| 160 | AMRX | Amneal Pharmaceuticals, Inc. | 5.40B | -2.14% | 300,938 | 3.05B |
| 161 | TVTX | Travere Therapeutics, Inc. | 5.35B | 1.27% | 353,462 | 536.20M |
| 162 | CAI | Caris Life Sciences, Inc. | 5.24B | 3.93% | 623,380 | 907.29M |
| 163 | SHC | Sotera Health Company | 5.13B | 1.41% | 538,448 | 1.19B |
| 164 | RDNT | RadNet, Inc. | 5.08B | 4.85% | 161,492 | 2.14B |
| 165 | DNTH | Dianthus Therapeutics, Inc. | 5.08B | -4.61% | 270,159 | 1.34M |
| 166 | CELC | Celcuity Inc. | 5.07B | -0.63% | 371,961 | - |
| 167 | TXG | 10x Genomics, Inc. | 5.00B | 2.76% | 625,168 | 638.78M |
| 168 | STVN | Stevanato Group S.p.A. | 4.96B | 0.44% | 39,125 | 1.39B |
| 169 | INDV | Indivior Pharmaceuticals, Inc. | 4.94B | -1.19% | 254,644 | 1.29B |
| 170 | ALHC | Alignment Healthcare, Inc. | 4.94B | 0.34% | 689,477 | 4.26B |
| 171 | KNSA | Kiniksa Pharmaceuticals International, plc | 4.84B | -1.63% | 187,703 | 754.05M |
| 172 | VCYT | Veracyte, Inc. | 4.74B | 1.12% | 197,518 | 541.74M |
| 173 | VKTX | Viking Therapeutics, Inc. | 4.52B | -0.23% | 825,390 | - |
| 174 | LIVN | LivaNova PLC | 4.51B | -0.13% | 82,507 | 1.43B |
| 175 | NVST | Envista Holdings Corporation | 4.43B | 3.34% | 288,077 | 2.81B |
| 176 | MMED | MiniMed Group, Inc. | 4.39B | 4.48% | 135,790 | 3.10B |
| 177 | ACAD | ACADIA Pharmaceuticals Inc. | 4.36B | 0.67% | 288,732 | 1.10B |
| 178 | LFST | LifeStance Health Group, Inc. | 4.32B | 4.01% | 1,011,642 | 1.49B |
| 179 | TNGX | Tango Therapeutics, Inc. | 4.31B | -4.70% | 597,069 | 56.99M |
| 180 | MMSI | Merit Medical Systems, Inc. | 4.22B | 1.96% | 111,613 | 1.54B |
| 181 | EWTX | Edgewise Therapeutics, Inc. | 4.22B | -3.57% | 359,332 | - |
| 182 | WAY | Waystar Holding Corp. | 4.20B | 6.67% | 559,451 | 1.16B |
| 183 | DNLI | Denali Therapeutics Inc. | 4.12B | 0.82% | 250,553 | - |
| 184 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.11B | 4.20% | 173,933 | 18.07M |
| 185 | NAMS | NewAmsterdam Pharma Company N.V. | 4.11B | 3.70% | 125,917 | 22.57M |
| 186 | IRTC | iRhythm Holdings, Inc. | 4.07B | 4.04% | 69,603 | 787.85M |
| 187 | DOCS | Doximity, Inc. | 4.05B | 6.65% | 1,108,026 | 644.86M |
| 188 | RLAY | Relay Therapeutics, Inc. | 4.00B | -1.87% | 641,331 | 10.68M |
| 189 | TLX | Telix Pharmaceuticals Limited | 4.00B | 2.08% | 49,819 | 803.79M |
| 190 | CON | Concentra Group Holdings Parent, Inc. | 3.92B | 2.89% | 622,513 | 2.23B |
| 191 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.85B | 0.02% | 239,237 | 596.96M |
| 192 | ICUI | ICU Medical, Inc. | 3.79B | 3.55% | 32,212 | 2.16B |
| 193 | BKD | Brookdale Senior Living Inc. | 3.78B | -1.62% | 717,259 | 3.00B |
| 194 | RCUS | Arcus Biosciences, Inc. | 3.76B | -3.05% | 285,154 | 236.00M |
| 195 | GPCR | Structure Therapeutics Inc. | 3.70B | -2.89% | 705,672 | - |
| 196 | WRBY | Warby Parker Inc. | 3.65B | -1.98% | 734,442 | 890.57M |
| 197 | RGC | Regencell Bioscience Holdings Limited | 3.64B | 20.69% | 445,911 | - |
| 198 | DYN | Dyne Therapeutics, Inc. | 3.62B | -1.35% | 294,076 | - |
| 199 | OGN | Organon & Co. | 3.57B | 0.33% | 635,669 | 6.16B |
| 200 | ADPT | Adaptive Biotechnologies Corporation | 3.55B | 3.40% | 1,033,561 | 295.41M |
| 201 | ALMS | Alumis Inc. | 3.50B | -2.31% | 275,384 | 8.40M |
| 202 | HAE | Haemonetics Corporation | 3.46B | 1.55% | 96,782 | 1.33B |
| 203 | IDYA | IDEAYA Biosciences, Inc. | 3.46B | -2.33% | 278,723 | 225.27M |
| 204 | BEAM | Beam Therapeutics Inc. | 3.42B | 0.17% | 624,899 | 164.01M |
| 205 | PBLS | Parabilis Medicines, Inc. | 3.42B | -1.99% | 111,352 | - |
| 206 | ELVN | Enliven Therapeutics, Inc. | 3.40B | -3.92% | 262,553 | - |
| 207 | NHC | National HealthCare Corporation | 3.37B | 2.05% | 21,882 | 1.53B |
| 208 | PRVA | Privia Health Group, Inc. | 3.34B | 2.95% | 364,989 | 2.25B |
| 209 | OPCH | Option Care Health, Inc. | 3.33B | 1.05% | 438,417 | 5.67B |
| 210 | ARQT | Arcutis Biotherapeutics, Inc. | 3.28B | -0.08% | 184,773 | 415.62M |
| 211 | ITGR | Integer Holdings Corporation | 3.25B | 2.30% | 45,103 | 1.86B |
| 212 | RARE | Ultragenyx Pharmaceutical Inc. | 3.23B | -1.38% | 644,561 | 670.00M |
| 213 | QURE | uniQure N.V. | 3.22B | 1.58% | 378,144 | 18.09M |
| 214 | VERA | Vera Therapeutics, Inc. | 3.06B | -0.54% | 300,376 | - |
| 215 | GRAL | GRAIL, Inc. | 3.01B | 2.58% | 107,558 | 156.12M |
| 216 | CLDX | Celldex Therapeutics, Inc. | 2.89B | -0.89% | 91,469 | 865.00K |
| 217 | CLOV | Clover Health Investments, Corp. | 2.89B | 4.77% | 2,183,552 | 2.21B |
| 218 | KLRA | Kailera Therapeutics, Inc. | 2.85B | -0.32% | 65,311 | - |
| 219 | ACHC | Acadia Healthcare Company, Inc. | 2.84B | 4.40% | 733,791 | 3.37B |
| 220 | IRON | Disc Medicine, Inc. | 2.81B | 0.44% | 141,207 | - |
| 221 | SUPN | Supernus Pharmaceuticals, Inc. | 2.73B | 1.25% | 147,229 | 776.83M |
| 222 | MBX | MBX Biosciences, Inc. | 2.71B | 3.24% | 249,574 | - |
| 223 | TARS | Tarsus Pharmaceuticals, Inc. | 2.70B | -0.32% | 115,430 | 535.08M |
| 224 | GRDN | Guardian Pharmacy Services, Inc. | 2.62B | -1.27% | 77,771 | 1.46B |
| 225 | TRVI | Trevi Therapeutics, Inc. | 2.58B | -2.47% | 566,684 | - |
| 226 | ESTA | Establishment Labs Holdings Inc. | 2.56B | 1.40% | 276,452 | 229.58M |
| 227 | HTFL | HeartFlow, Inc. | 2.53B | -0.20% | 350,810 | 191.42M |
| 228 | NRIX | Nurix Therapeutics, Inc. | 2.52B | 0.62% | 341,332 | 71.78M |
| 229 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.49B | -2.15% | 1,532,150 | 885.72M |
| 230 | ASTH | Astrana Health, Inc. | 2.48B | 7.66% | 351,228 | 3.53B |
| 231 | TMDX | TransMedics Group, Inc. | 2.47B | 7.48% | 354,364 | 635.89M |
| 232 | SLS | SELLAS Life Sciences Group, Inc. | 2.46B | -10.43% | 6,008,990 | - |
| 233 | NTLA | Intellia Therapeutics, Inc. | 2.43B | 2.84% | 1,421,276 | 66.09M |
| 234 | MLYS | Mineralys Therapeutics, Inc. | 2.43B | 2.11% | 322,653 | - |
| 235 | AXGN | Axogen, Inc. | 2.42B | -1.52% | 281,489 | 238.11M |
| 236 | IMNM | Immunome, Inc. | 2.41B | 0.47% | 577,971 | 4.02M |
| 237 | KOD | Kodiak Sciences Inc. | 2.36B | -2.90% | 156,141 | - |
| 238 | PHVS | Pharvaris N.V. | 2.36B | -2.46% | 32,098 | - |
| 239 | PGNY | Progyny, Inc. | 2.34B | 3.71% | 192,393 | 1.29B |
| 240 | ABCL | AbCellera Biologics Inc. | 2.30B | -4.01% | 3,219,245 | 79.21M |
| 241 | PBH | Prestige Consumer Healthcare Inc. | 2.30B | 2.51% | 135,845 | 1.09B |
| 242 | VCEL | Vericel Corporation | 2.29B | 0.97% | 179,314 | 292.09M |
| 243 | NKTR | Nektar Therapeutics | 2.28B | -3.18% | 289,381 | 55.63M |
| 244 | AGIO | Agios Pharmaceuticals, Inc. | 2.25B | 2.16% | 235,793 | 66.05M |
| 245 | LMAT | LeMaitre Vascular, Inc. | 2.25B | 2.59% | 199,463 | 256.28M |
| 246 | BHVN | Biohaven Ltd. | 2.23B | -0.47% | 834,106 | - |
| 247 | XRAY | DENTSPLY SIRONA Inc. | 2.21B | 4.05% | 1,151,258 | 3.68B |
| 248 | SGRY | Surgery Partners, Inc. | 2.20B | 0.89% | 295,564 | 3.34B |
| 249 | ZLAB | Zai Lab Limited | 2.18B | 2.05% | 128,277 | 453.28M |
| 250 | KARD | Kardigan, Inc. | 2.17B | 1.64% | 114,518 | - |
| 251 | OCUL | Ocular Therapeutix, Inc. | 2.17B | 0.71% | 454,022 | 52.04M |
| 252 | TSHA | Taysha Gene Therapies, Inc. | 2.15B | -1.10% | 832,742 | 7.47M |
| 253 | GENB | Generate Biomedicines, Inc. | 2.13B | -1.48% | 231,270 | 30.30M |
| 254 | BFLY | Butterfly Network, Inc. | 2.13B | -3.44% | 2,424,839 | 102.92M |
| 255 | UFPT | UFP Technologies, Inc. | 2.12B | 3.27% | 60,230 | 608.85M |
| 256 | VRDN | Viridian Therapeutics, Inc. | 2.10B | 3.65% | 1,153,188 | 70.92M |
| 257 | AUPH | Aurinia Pharmaceuticals Inc. | 2.10B | -3.71% | 519,405 | 298.30M |
| 258 | WGS | GeneDx Holdings Corp. | 2.09B | 2.75% | 199,763 | 442.68M |
| 259 | HRMY | Harmony Biosciences Holdings, Inc. | 2.09B | -0.80% | 93,413 | 899.11M |
| 260 | MD | Pediatrix Medical Group, Inc. | 2.09B | 2.68% | 134,574 | 1.93B |
| 261 | NEOG | Neogen Corporation | 2.08B | 6.12% | 175,965 | 870.56M |
| 262 | GLUE | Monte Rosa Therapeutics, Inc. | 2.07B | 1.12% | 344,584 | 42.95M |
| 263 | STOK | Stoke Therapeutics, Inc. | 2.05B | 0.55% | 338,730 | 32.08M |
| 264 | SEM | Select Medical Holdings Corporation | 2.05B | - | - | 5.52B |
| 265 | PVLA | Palvella Therapeutics, Inc. | 2.03B | -7.36% | 120,804 | - |
| 266 | ADMA | ADMA Biologics, Inc. | 2.02B | 3.94% | 720,267 | 509.86M |
| 267 | RXRX | Recursion Pharmaceuticals, Inc. | 1.98B | 1.77% | 13,692,188 | 66.41M |
| 268 | PLSE | Pulse Biosciences, Inc. | 1.98B | 3.25% | 52,445 | 751.00K |
| 269 | PGEN | Precigen, Inc. | 1.98B | -2.63% | 2,312,630 | 31.60M |
| 270 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.98B | -1.00% | 229,854 | -665.00K |
| 271 | LKFT | Lakefront Biotherapeutics NV | 1.97B | -0.67% | 128,085 | 1.20B |
| 272 | OMCL | Omnicell, Inc. | 1.95B | 3.49% | 63,806 | 1.23B |
| 273 | NEO | NeoGenomics, Inc. | 1.95B | 2.74% | 747,132 | 745.97M |
| 274 | SNDA | Sonida Senior Living, Inc. | 1.94B | 1.91% | 167,744 | 367.34M |
| 275 | AVAH | Aveanna Healthcare Holdings Inc. | 1.94B | 3.85% | 311,256 | 2.52B |
| 276 | ANAB | AnaptysBio, Inc. | 1.93B | -1.57% | 83,733 | 232.39M |
| 277 | RAPP | Rapport Therapeutics, Inc. | 1.93B | -3.36% | 84,003 | 20.00M |
| 278 | ABSI | Absci Corporation | 1.92B | -2.33% | 1,744,368 | 1.84M |
| 279 | BCAX | Bicara Therapeutics Inc. | 1.92B | -1.75% | 170,147 | - |
| 280 | ATAI | AtaiBeckley Inc. | 1.91B | -1.33% | 1,619,476 | 3.49M |
| 281 | NUVB | Nuvation Bio Inc. | 1.91B | -3.52% | 2,700,109 | 143.05M |
| 282 | SRPT | Sarepta Therapeutics, Inc. | 1.90B | 0.39% | 856,450 | 2.18B |
| 283 | SION | Sionna Therapeutics, Inc. | 1.89B | -4.75% | 141,117 | - |
| 284 | ADUS | Addus HomeCare Corporation | 1.88B | 2.52% | 37,529 | 1.45B |
| 285 | SNDX | Syndax Pharmaceuticals, Inc. | 1.87B | -3.25% | 588,500 | 217.17M |
| 286 | AGL | agilon health, inc. | 1.87B | 4.78% | 55,354 | 5.82B |
| 287 | NBTX | Nanobiotix S.A. | 1.86B | 0.21% | 35,598 | 38.27M |
| 288 | ZYME | Zymeworks Inc. | 1.85B | -3.10% | 148,177 | 81.26M |
| 289 | HCM | HUTCHMED (China) Limited | 1.85B | 0.55% | 7,034 | 548.51M |
| 290 | CMPS | COMPASS Pathways plc | 1.84B | -3.39% | 1,655,859 | - |
| 291 | TRLV | Trulieve Cannabis Corp. | 1.84B | -2.54% | 282,032 | 1.17B |
| 292 | ALMR | Alamar Biosciences, Inc. | 1.83B | -2.58% | 99,346 | 87.16M |
| 293 | MESO | Mesoblast Limited | 1.83B | 4.43% | 61,733 | 65.38M |
| 294 | BHC | Bausch Health Companies Inc. | 1.83B | -0.81% | 346,001 | 10.53B |
| 295 | URGN | UroGen Pharma Ltd. | 1.82B | 1.63% | 165,199 | 140.49M |
| 296 | GHRS | GH Research PLC | 1.82B | -1.53% | 59,702 | - |
| 297 | TYRA | Tyra Biosciences, Inc. | 1.81B | -4.70% | 142,290 | - |
| 298 | NVCR | NovoCure Limited | 1.81B | 3.07% | 252,529 | 674.41M |
| 299 | IOVA | Iovance Biotherapeutics, Inc. | 1.80B | -3.12% | 5,338,949 | 285.61M |
| 300 | ANIP | ANI Pharmaceuticals, Inc. | 1.78B | 1.17% | 59,008 | 923.71M |
| 301 | AKTS | Aktis Oncology, Inc. | 1.75B | -1.74% | 101,323 | 8.28M |
| 302 | HCSG | Healthcare Services Group, Inc. | 1.74B | 3.18% | 90,050 | 1.85B |
| 303 | FTRE | Fortrea Holdings Inc. | 1.73B | 5.06% | 369,589 | 2.71B |
| 304 | ZBIO | Zenas BioPharma, Inc. | 1.71B | 7.01% | 412,145 | 10.00M |
| 305 | DMRA | Damora Therapeutics, Inc. | 1.66B | 3.88% | 88,844 | - |
| 306 | MAZE | Maze Therapeutics, Inc. | 1.65B | 0.20% | 113,905 | 20.00M |
| 307 | INVA | Innoviva, Inc. | 1.65B | -1.48% | 128,047 | 420.69M |
| 308 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.63B | 1.36% | 493,550 | 204.73M |
| 309 | INNV | InnovAge Holding Corp. | 1.62B | 0.76% | 88,015 | 949.17M |
| 310 | TDOC | Teladoc Health, Inc. | 1.62B | 5.78% | 1,776,618 | 2.51B |
| 311 | VIR | Vir Biotechnology, Inc. | 1.62B | -5.79% | 552,334 | 65.50M |
| 312 | KMTS | Kestra Medical Technologies, Ltd. | 1.62B | 8.86% | 102,505 | 83.72M |
| 313 | AVBP | ArriVent BioPharma, Inc. | 1.61B | -0.30% | 101,418 | - |
| 314 | MPLT | MapLight Therapeutics, Inc. | 1.61B | -0.85% | 128,121 | - |
| 315 | COAG | Hemab Therapeutics Holdings, Inc. | 1.61B | -6.15% | 40,258 | - |
| 316 | MLTX | MoonLake Immunotherapeutics | 1.61B | -0.10% | 331,050 | - |
| 317 | HROW | Harrow, Inc. | 1.59B | 0.64% | 241,287 | 268.68M |
| 318 | IMCR | Immunocore Holdings plc | 1.59B | -1.61% | 133,187 | 412.81M |
| 319 | AAPG | Ascentage Pharma Group International | 1.56B | 3.08% | 2,670 | 82.08M |
| 320 | SVRA | Savara Inc. | 1.56B | -0.32% | 398,580 | - |
| 321 | NVAX | Novavax, Inc. | 1.55B | 0.27% | 713,314 | 596.34M |
| 322 | SEPN | Septerna, Inc. | 1.54B | 1.91% | 87,994 | 72.26M |
| 323 | CDNA | CareDx, Inc. | 1.51B | 2.77% | 105,361 | 412.82M |
| 324 | ATRC | AtriCure, Inc. | 1.46B | 3.09% | 227,273 | 552.16M |
| 325 | AHCO | AdaptHealth Corp. | 1.45B | 4.65% | 388,890 | 3.29B |
| 326 | INBX | Inhibrx Biosciences, Inc. | 1.45B | 4.21% | 109,896 | 1.30M |
| 327 | ARDT | Ardent Health, Inc. | 1.45B | 2.64% | 184,303 | 6.43B |
| 328 | PRGO | Perrigo Company plc | 1.44B | 0.48% | 533,996 | 4.18B |
| 329 | STAA | STAAR Surgical Company | 1.44B | 1.01% | 89,127 | 290.38M |
| 330 | IART | Integra LifeSciences Holdings Corporation | 1.44B | 2.73% | 93,868 | 1.64B |
| 331 | PSNL | Personalis, Inc. | 1.43B | 1.72% | 1,133,821 | 64.52M |
| 332 | BLFS | BioLife Solutions, Inc. | 1.41B | 2.16% | 194,813 | 101.66M |
| 333 | XERS | Xeris Biopharma Holdings, Inc. | 1.40B | 2.65% | 759,405 | 314.85M |
| 334 | CAPR | Capricor Therapeutics, Inc. | 1.40B | 0.29% | 412,459 | 11.13M |
| 335 | ATEC | Alphatec Holdings, Inc. | 1.39B | 4.45% | 1,402,237 | 787.08M |
| 336 | OMDA | Omada Health, Inc. | 1.37B | 4.78% | 469,613 | 283.30M |
| 337 | PRCT | PROCEPT BioRobotics Corporation | 1.37B | 6.22% | 474,550 | 322.02M |
| 338 | AVLN | Avalyn Pharma Inc. | 1.36B | -7.05% | 99,698 | - |
| 339 | IMTX | Immatics N.V. | 1.35B | -2.37% | 108,272 | 43.00M |
| 340 | INSP | Inspire Medical Systems, Inc. | 1.35B | 4.89% | 254,860 | 915.25M |
| 341 | PNTG | The Pennant Group, Inc. | 1.31B | 2.30% | 78,104 | 1.02B |
| 342 | MNKD | MannKind Corporation | 1.31B | -0.47% | 418,756 | 360.78M |
| 343 | JBIO | Jade Biosciences, Inc. | 1.31B | -0.90% | 122,525 | - |
| 344 | AMN | AMN Healthcare Services, Inc. | 1.30B | 3.78% | 85,642 | 3.42B |
| 345 | CRVS | Corvus Pharmaceuticals, Inc. | 1.29B | 2.88% | 584,070 | - |
| 346 | QDEL | QuidelOrtho Corporation | 1.29B | 8.14% | 345,986 | 2.66B |
| 347 | ARDX | Ardelyx, Inc. | 1.29B | 2.25% | 1,994,353 | 427.68M |
| 348 | AHG | Akso Health Group | 1.28B | - | 439 | 14.84M |
| 349 | PAHC | Phibro Animal Health Corporation | 1.27B | 0.03% | 26,305 | 1.50B |
| 350 | EYPT | EyePoint, Inc. | 1.25B | 4.62% | 764,679 | 7.61M |
| 351 | ALVO | Alvotech | 1.24B | -0.27% | 193,461 | 562.04M |
| 352 | IRMD | IRADIMED CORPORATION | 1.24B | 1.51% | 41,686 | 86.28M |
| 353 | AZTA | Azenta, Inc. | 1.24B | 5.29% | 121,452 | 596.48M |
| 354 | SDGR | Schrödinger, Inc. | 1.22B | 0.74% | 341,265 | 254.91M |
| 355 | MGTX | MeiraGTx Holdings plc | 1.22B | -2.29% | 692,233 | 79.76M |
| 356 | NUTX | Nutex Health Inc. | 1.21B | 3.28% | 48,072 | 879.95M |
| 357 | ENOV | Enovis Corporation | 1.19B | 0.19% | 230,510 | 2.28B |
| 358 | COLL | Collegium Pharmaceutical, Inc. | 1.19B | 1.52% | 66,292 | 796.33M |
| 359 | XNCR | Xencor, Inc. | 1.18B | -1.40% | 256,664 | 97.36M |
| 360 | AVNS | Avanos Medical, Inc. | 1.17B | 0.14% | 104,639 | 715.90M |
| 361 | SPTX | Seaport Therapeutics, Inc. | 1.15B | -0.69% | 22,541 | - |
| 362 | ORIC | ORIC Pharmaceuticals, Inc. | 1.15B | 2.59% | 351,380 | - |
| 363 | DRTS | Alpha Tau Medical Ltd. | 1.15B | 1.35% | 469,152 | - |
| 364 | OPK | OPKO Health, Inc. | 1.15B | 1.33% | 708,617 | 581.12M |
| 365 | WVE | Wave Life Sciences Ltd. | 1.14B | 2.41% | 638,022 | 71.80M |
| 366 | AORT | Artivion, Inc. | 1.14B | 4.18% | 133,726 | 458.69M |
| 367 | LMRI | Lumexa Imaging Holdings, Inc. | 1.13B | 3.99% | 121,130 | 1.03B |
| 368 | BIOA | BioAge Labs, Inc. | 1.08B | -0.47% | 140,579 | 10.32M |
| 369 | CERT | Certara, Inc. | 1.08B | 6.41% | 953,564 | 419.75M |
| 370 | CGEM | Cullinan Therapeutics, Inc. | 1.08B | -3.35% | 140,781 | - |
| 371 | SANA | Sana Biotechnology, Inc. | 1.08B | 2.87% | 858,566 | - |
| 372 | USPH | U.S. Physical Therapy, Inc. | 1.07B | 2.46% | 43,557 | 787.69M |
| 373 | OLMA | Olema Pharmaceuticals, Inc. | 1.07B | -2.08% | 837,804 | - |
| 374 | TNDM | Tandem Diabetes Care, Inc. | 1.06B | 2.72% | 242,584 | 1.03B |
| 375 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.05B | -1.04% | 720,644 | 69.64M |
| 376 | CRON | Cronos Group Inc. | 1.03B | 3.78% | 562,690 | 159.54M |
| 377 | GDRX | GoodRx Holdings, Inc. | 1.02B | 5.03% | 711,749 | 787.89M |
| 378 | CNMD | CONMED Corporation | 1.02B | 3.09% | 56,068 | 1.37B |
| 379 | EVO | Evotec SE | 1.01B | 3.09% | 25,271 | 859.03M |
| 380 | ETON | Eton Pharmaceuticals, Inc. | 999.82M | 0.83% | 42,326 | 86.93M |
| 381 | VOR | Vor Biopharma Inc. | 989.43M | -0.81% | 318,642 | - |
| 382 | SLDB | Solid Biosciences Inc. | 988.43M | 0.50% | 239,007 | - |
| 383 | PCRX | Pacira BioSciences, Inc. | 981.73M | -1.66% | 116,165 | 734.86M |
| 384 | PHAR | Pharming Group N.V. | 969.86M | -2.09% | 1,375 | 369.49M |
| 385 | KURA | Kura Oncology, Inc. | 963.65M | -1.05% | 533,604 | 71.64M |
| 386 | DBVT | DBV Technologies S.A. | 953.36M | -3.11% | 38,506 | 5.74M |
| 387 | REPL | Replimune Group, Inc. | 952.78M | 2.53% | 840,943 | - |
| 388 | AVTX | Avalo Therapeutics, Inc. | 951.96M | -2.00% | 306,995 | 59.00K |
| 389 | JANX | Janux Therapeutics, Inc. | 945.87M | 0.98% | 363,297 | 13.73M |
| 390 | ABUS | Arbutus Biopharma Corporation | 942.25M | -0.63% | 451,439 | 191.45M |
| 391 | INMD | InMode Ltd. | 932.64M | 0.68% | 98,394 | 374.64M |
| 392 | AVR | Anteris Technologies Global Corp. | 930.59M | -2.94% | 810,774 | 1.85M |
| 393 | LBRX | LB Pharmaceuticals Inc | 923.10M | -0.82% | 40,387 | - |
| 394 | ANNX | Annexon, Inc. | 922.43M | -1.40% | 1,519,735 | - |
| 395 | ANRO | Alto Neuroscience, Inc. | 908.23M | -1.93% | 67,333 | - |
| 396 | AMPH | Amphastar Pharmaceuticals, Inc. | 884.94M | -0.55% | 71,897 | 720.53M |
| 397 | DSGN | Design Therapeutics, Inc. | 880.96M | -2.52% | 233,289 | - |
| 398 | TBPH | Theravance Biopharma, Inc. | 876.40M | - | 210,939 | 109.78M |
| 399 | ODTX | Odyssey Therapeutics, Inc. | 874.73M | -2.35% | 46,393 | 1.06M |
| 400 | TALK | Talkspace, Inc. | 870.23M | -0.10% | 213,812 | 238.37M |
| 401 | IVA | Inventiva S.A. | 869.21M | -4.23% | 197,570 | 7.94M |
| 402 | PHAT | Phathom Pharmaceuticals, Inc. | 853.08M | -1.01% | 107,395 | 204.89M |
| 403 | ZVRA | Zevra Therapeutics, Inc. | 837.96M | -1.15% | 247,611 | 122.29M |
| 404 | BVS | Bioventus Inc. | 827.83M | 4.98% | 229,027 | 576.30M |
| 405 | HSTM | HealthStream, Inc. | 824.45M | 3.56% | 29,555 | 311.78M |
| 406 | OCS | Oculis Holding AG | 821.88M | -1.87% | 112,751 | 1.40M |
| 407 | GERN | Geron Corporation | 814.73M | -0.78% | 3,923,628 | 196.12M |
| 408 | SPRY | ARS Pharmaceuticals, Inc. | 813.29M | 2.25% | 235,520 | 98.99M |
| 409 | ESPR | Esperion Therapeutics, Inc. | 812.20M | -0.16% | 2,411,410 | 418.24M |
| 410 | GMRS | GMR Solutions Inc. | 810.18M | -2.98% | 150,685 | 5.83B |
| 411 | CTMX | CytomX Therapeutics, Inc. | 796.79M | -2.40% | 1,124,456 | 35.54M |
| 412 | SSII | SS Innovations International, Inc. | 770.53M | -7.23% | 32,894 | 48.47M |
| 413 | CLYM | Climb Bio, Inc. | 767.86M | 2.84% | 497,141 | - |
| 414 | CADL | Candel Therapeutics, Inc. | 762.74M | 1.07% | 542,046 | - |
| 415 | CBLL | CeriBell, Inc. | 758.10M | 2.72% | 93,961 | 95.07M |
| 416 | AURA | Aura Biosciences, Inc. | 752.24M | -3.94% | 121,942 | - |
| 417 | SIBN | SI-BONE, Inc. | 750.39M | 3.68% | 138,213 | 206.22M |
| 418 | ACRS | Aclaris Therapeutics, Inc. | 747.20M | 1.13% | 780,688 | 8.37M |
| 419 | CSTL | Castle Biosciences, Inc. | 738.38M | 2.08% | 46,702 | 339.92M |
| 420 | BBNX | Beta Bionics, Inc. | 733.04M | 4.98% | 188,141 | 110.24M |
| 421 | SLBT | SL Science Holding Limited | 728.93M | -5.85% | 146,304 | - |
| 422 | SGP | SpyGlass Pharma, Inc. | 717.81M | -3.55% | 18,714 | - |
| 423 | RIGL | Rigel Pharmaceuticals, Inc. | 717.14M | -0.92% | 45,861 | 299.77M |
| 424 | ALLO | Allogene Therapeutics, Inc. | 714.47M | -0.48% | 3,152,873 | 22.00K |
| 425 | DNA | Ginkgo Bioworks Holdings, Inc. | 708.12M | 9.38% | 737,210 | 151.40M |
| 426 | IMMX | Immix Biopharma, Inc. | 705.49M | -3.88% | 403,097 | - |
| 427 | DRUG | Bright Minds Biosciences Inc. | 704.76M | -1.77% | 128,420 | - |
| 428 | TENX | Tenax Therapeutics, Inc. | 704.36M | -5.25% | 278,485 | - |
| 429 | ACHV | Achieve Life Sciences, Inc. | 703.21M | 4.90% | 1,388,420 | - |
| 430 | FDMT | 4D Molecular Therapeutics, Inc. | 698.15M | 0.41% | 358,489 | 88.24M |
| 431 | PRME | Prime Medicine, Inc. | 698.09M | 4.74% | 1,471,128 | 4.03M |
| 432 | TCMD | Tactile Systems Technology, Inc. | 691.35M | 2.92% | 29,032 | 343.52M |
| 433 | OMER | Omeros Corporation | 691.18M | 0.42% | 184,775 | 9.89M |
| 434 | EIKN | Eikon Therapeutics, Inc. | 688.64M | -2.53% | 111,770 | - |
| 435 | RLMD | Relmada Therapeutics, Inc. | 675.49M | -6.94% | 319,515 | - |
| 436 | IRWD | Ironwood Pharmaceuticals, Inc. | 674.91M | -2.61% | 374,469 | 361.51M |
| 437 | PHR | Phreesia, Inc. | 673.75M | 5.93% | 195,511 | 495.59M |
| 438 | RGNX | REGENXBIO Inc. | 668.45M | 7.93% | 907,712 | 87.82M |
| 439 | EVH | Evolent Health, Inc. | 659.70M | 8.21% | 814,899 | 1.89B |
| 440 | MNPR | Monopar Therapeutics Inc. | 654.94M | 5.59% | 57,596 | - |
| 441 | CRMD | CorMedix Inc. | 648.80M | 5.35% | 369,828 | 400.05M |
| 442 | ALT | Altimmune, Inc. | 646.63M | 9.38% | 3,006,121 | 36.00K |
| 443 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 642.86M | 5.31% | 188,112 | - |
| 444 | TRAX | First Tracks Biotherapeutics, Inc. | 639.23M | -8.95% | 120,550 | - |
| 445 | TECX | Tectonic Therapeutic, Inc. | 626.08M | -3.48% | 56,798 | - |
| 446 | BWAY | BrainsWay Ltd. | 618.99M | 1.16% | 11,929 | 56.22M |
| 447 | AGMB | AgomAb Therapeutics NV | 605.75M | -5.24% | 40,953 | - |
| 448 | FLGT | Fulgent Genetics, Inc. | 596.41M | 2.34% | 77,692 | 320.35M |
| 449 | FTH | Faeth Therapeutics, Inc. | 592.81M | -8.02% | 29,398 | - |
| 450 | GYRE | Gyre Therapeutics, Inc. | 592.09M | -1.67% | 16,748 | 117.05M |
| 451 | CBIO | Crescent Biopharma, Inc. | 591.48M | -1.11% | 32,987 | 11.88M |
| 452 | CERS | Cerus Corporation | 591.09M | 1.03% | 1,211,031 | 216.56M |
| 453 | CTEV | Claritev Corporation | 590.19M | 1.50% | 21,215 | 978.76M |
| 454 | CTKB | Cytek Biosciences, Inc. | 586.31M | 2.48% | 213,819 | 204.17M |
| 455 | CTNM | Contineum Therapeutics, Inc. | 583.60M | -4.76% | 82,495 | - |
| 456 | NNNN | Anbio Biotechnology | 577.17M | -4.08% | 7,078 | 8.65M |
| 457 | MDXG | MiMedx Group, Inc. | 575.68M | 0.39% | 150,173 | 389.42M |
| 458 | PROK | ProKidney Corp. | 575.42M | -6.62% | 504,069 | 889.00K |
| 459 | CLPT | ClearPoint Neuro, Inc. | 570.10M | 6.56% | 119,239 | 40.61M |
| 460 | TOI | The Oncology Institute, Inc. | 552.91M | 1.84% | 458,767 | 545.76M |
| 461 | ANGO | AngioDynamics, Inc. | 551.04M | 1.61% | 47,504 | 313.73M |
| 462 | NPCE | NeuroPace, Inc. | 550.95M | 1.70% | 28,984 | 99.53M |
| 463 | MYGN | Myriad Genetics, Inc. | 548.27M | 1.66% | 267,120 | 829.00M |
| 464 | ASMB | Assembly Biosciences, Inc. | 537.34M | -1.33% | 85,347 | 71.10M |
| 465 | TLRY | Tilray Brands, Inc. | 536.77M | 0.22% | 1,924,560 | 858.28M |
| 466 | PACB | Pacific Biosciences of California, Inc. | 535.79M | 2.68% | 1,076,974 | 160.03M |
| 467 | RZLT | Rezolute, Inc. | 533.83M | -1.73% | 841,075 | - |
| 468 | AQST | Aquestive Therapeutics, Inc. | 533.79M | 2.28% | 277,183 | 50.27M |
| 469 | XOMA | XOMA Royalty Corporation | 532.74M | -0.05% | 20,176 | 48.56M |
| 470 | ARVN | Arvinas, Inc. | 525.85M | -1.93% | 126,447 | 89.40M |
| 471 | STTK | Shattuck Labs, Inc. | 523.73M | -1.59% | 686,063 | 1.00M |
| 472 | EDIT | Editas Medicine, Inc. | 523.30M | 5.25% | 747,417 | 38.69M |
| 473 | NVCT | Nuvectis Pharma, Inc. | 523.08M | 7.23% | 249,866 | - |
| 474 | KYTX | Kyverna Therapeutics, Inc. | 521.62M | -3.70% | 195,091 | - |
| 475 | NGNE | Neurogene Inc. | 517.67M | 4.17% | 143,849 | 925.00K |
| 476 | FBRX | Forte Biosciences, Inc. | 513.39M | -1.13% | 78,227 | - |
| 477 | STRO | Sutro Biopharma, Inc. | 510.87M | -7.14% | 70,351 | 99.61M |
| 478 | WEAV | Weave Communications, Inc. | 510.41M | 7.10% | 169,851 | 248.72M |
| 479 | OCGN | Ocugen, Inc. | 506.09M | -2.29% | 2,636,430 | 4.47M |
| 480 | SLN | Silence Therapeutics plc | 505.40M | -2.55% | 166,772 | 839.00K |
| 481 | PRTA | Prothena Corporation plc | 505.21M | -1.43% | 105,661 | 57.94M |
| 482 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 5.42M |
| 483 | ZURA | Zura Bio Limited | 503.49M | -10.17% | 614,968 | - |
| 484 | NRC | NRC Health | 502.57M | 3.38% | 11,904 | 138.64M |
| 485 | KIDS | OrthoPediatrics Corp. | 501.88M | 2.14% | 27,735 | 243.30M |
| 486 | EVMN | Evommune, Inc. | 495.97M | 3.61% | 672,867 | 10.00M |
| 487 | OVID | Ovid Therapeutics Inc. | 491.80M | -2.04% | 354,892 | 7.12M |
| 488 | PRLD | Prelude Therapeutics Incorporated | 491.42M | -7.04% | 179,808 | 16.72M |
| 489 | VALN | Valneva SE | 488.58M | -0.57% | 4,652 | 180.25M |
| 490 | CABA | Cabaletta Bio, Inc. | 483.46M | -4.66% | 1,629,141 | - |
| 491 | SOPH | SOPHiA GENETICS SA | 479.88M | -0.87% | 172,430 | 81.18M |
| 492 | SGMT | Sagimet Biosciences Inc. | 473.64M | -0.78% | 377,693 | - |
| 493 | ARTV | Artiva Biotherapeutics, Inc. | 465.72M | -1.19% | 81,886 | 251.00K |
| 494 | CCCC | C4 Therapeutics, Inc. | 464.38M | -10.06% | 1,911,706 | 34.86M |
| 495 | CYH | Community Health Systems, Inc. | 462.57M | 2.25% | 218,477 | 12.29B |
| 496 | SRTA | Strata Critical Medical, Inc. | 460.32M | 0.95% | 338,740 | 228.58M |
| 497 | SI | Shoulder Innovations, Inc. | 456.24M | 8.48% | 40,563 | 53.89M |
| 498 | VMD | Viemed Healthcare, Inc. | 453.33M | 3.73% | 83,965 | 286.57M |
| 499 | DCTH | Delcath Systems, Inc. | 451.20M | 3.81% | 103,656 | 90.44M |
| 500 | MOBI | Mobia Medical, Inc. | 450.86M | 1.19% | 36,258 | 38.45M |